CFTR and cystic fibrosis: Although CF is incurable, pharmacotherapy using the CFTR potentiator drug ivacaftor (VX‐770) to stimulate gating (Po), and the corrector drugs tezacaftor (VX‐661) and elexacaftor (VX‐445) to boost channel surface expression (N), has shown remarkable clinical success.